Skip to main content

Table 3 Association between degree of lung function impairment and all-cause mortality restricted to people without previous history of COPD and never smokers

From: Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study

Type of groups

No. of persons

No. of deaths

Person-years of follow-up

Deaths per 100 person-years (95% CI)

Model 1 adjusted HR (95% CI)

Model 2 Adjusted HR (95% CI)

No previous history of COPD and pulmonary symptoms

   

FEV1% predicted impairment groups*

   

 Normal

14,436

2413

190,254

1.27 (1.22–1.32)

1.00

1.00

 Mild

1427

374

18,736

2.00 (1.80–2.21)

1.51 (1.35–1.68)

1.20 (1.07–1.35)

 Moderate

516

175

6463

2.71 (2.33–3.14)

1.88 (1.60–2.21)

1.41 (1.20–1.66)

 Moderate-severe

196

76

2337

3.25 (2.60–4.07)

2.12 (1.64–2.73)

1.59 (1.26–2.02)

 Severe

117

38

1463

2.60 (1.89–3.57)

1.83 (1.30–2.57)

1.30 (0.93–1.82)

 Very severe

31

12

360

3.34 (1.89–5.87)

3.07 (1.68–5.61)

2.13 (1.21–3.77)

Never smokers

   

FEV1% predicted impairment groups*

   

 Normal

11,233

1537

147,841

1.04 (0.99–1.09)

1.00

1.00

 Mild

1077

246

14,057

1.75 (1.54–1.98)

1.56 (1.37–1.79)

1.40 (1.21–1.62)

 Moderate

407

111

5179

2.14 (1.78–2.58)

1.89 (1.55–2.30)

1.61 (1.32–1.98)

 Moderate-severe

176

59

2096

2.81 (2.18–3.63)

2.50 (1.89–3.31)

2.17 (1.66–2.83)

 Severe

104

33

1294

2.55 (1.81–3.59)

2.39 (1.65–3.45)

2.14 (1.50–3.07)

 Very severe

36

19

397

4.79 (3.06–7.51)

4.06 (2.43–6.80)

4.03 (2.55–6.35)

  1. FEV1, forced expiratory volume in 1 s; CI, confidence interval; HR, hazard ratio
  2. *Sex-specific predicted values of FEV1 (FEV1%) standardized for age and height based on NHANES III equations
  3. Adjusted for age, sex and country
  4. Adjusted for age, sex, occupation and education; alcohol consumption, smoking status, level of physical activity and body mass index; history of hypertension, ischemic heart disease, myocardial infarction, stroke